Crescent Biopharma
IPOPublic · $211.0M raised
- Business Model
- B2B
- Website
- crescentbiopharma.com
- Total Funding
- $211.0M
- Last Round
- $200.0M Private EquityOct 2024
- Rounds
- 2
- Type
- Public
About
Clinical-stage oncology company developing next-wave cancer therapies for patients.
Summary
Crescent Biopharma is a Biotech company. It has raised $211.0M in total across 2 rounds, most recently a $200.0M Private Equity round in Oct 2024. Investors include Fairmount and Venrock.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...